Here are relevant reports on : ai-agents-healthcare-market
-
Industrial Cleaning Chemicals Market by Ingredient (Surfactants, Solvents, Chelating Agents), Product (General & Medical Cleaning), Application (Manufacturing & Commercial Offices, Healthcare, Retail & Food Service), and Region - Global Forecast to 2028
The industrial cleaning chemicals market is expected to grow from USD 53.5 billion in 2023 to USD 67.0 billion by 2028, at a CAGR of 4.6% during the forecast period. Major players operating in the industrial cleaning chemicals market are BASF SE (Germany), Dow Inc. (US), Clariant AG (Switzerland), Evonik Industries AG (Germany), Solvay SA (Belgium), Diversey Holdings Ltd. (US), Stepan Company (US), Ecolab Inc. (US), Pilot Chemical Corp. (US), and DuPont de Nemours, Inc. (US), among others.
- Published: April 2023
- Price: $ 4950
- TOC Available:
-
Artificial Intelligence (AI) Market by Offering [Hardware (AI Chips, Memory, Storage), Software, Services], Technology (ML, NLP, Generative AI, Neurosymbolic AI), Business Function (Operations & Supply Chain, Sales & Marketing) - Global Forecast to 2033
The Artificial intelligence (AI) market was estimated to be worth USD 601.93 billion in 2026 and is projected to reach USD 3,638.08 billion by 2033, at a CAGR of 29.3%. The major players in the artificial intelligence market include NVIDIA (US), Microsoft (US), Alphabet (US), Amazon Web Services (US), OpenAI (US), Meta (US), IBM (US), Anthropic (US), Cohere (Canada), Mistral AI (France), and Anyscale (US), among others.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Generative AI Cybersecurity Market by Generative AI-based Cybersecurity (SIEM, Risk Assessment, Threat Intelligence), Cybersecurity Software for Generative AI (AI Model Security), Security Type (Data Encryption, Access Control) - Global Forecast to 2031
The generative AI cybersecurity market is undergoing rapid expansion, with estimates projecting a substantial market value surge from USD 8.65 billion in 2025 to USD 35.50 billion by 2031, at a CAGR of 26.5% during the forecast period. Microsoft (US), IBM (US), Google (US), SentinelOne (US), AWS (US), NVIDIA (US), Cisco (US), CrowdStrike (US), Fortinet (US), Zscaler (US), Trend Micro (Japan), Palo Alto Networks (US), BlackBerry (Canada), Darktrace (UK), F5 (US), Okta (US), Sangfor (China), SecurityScorecard (US), Sophos (UK), Broadcom (US), Trellix (US), Veracode (US), LexisNexis (US), Abnormal Security (US), Adversa AI (Israel), Aquasec (US), BigID (US), Checkmarx (US), Cohesity (US), Credo AI (US), NeuralTrust (Spain), Cybereason (US), DeepKeep (Israel), Elastic NV (US), Flashpoint (US), Lakera (US), MOSTLY AI (Austria), Recorded Future (US), Secureframe (US), Skyflow (US), SlashNext (US), Snyk (US), Tenable (US), TrojAI (Canada), VirusTotal (Spain), XenonStack (UAE), and Zerofox (US) are leading plaryes in generative AI cybersecurity market
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Citizen Services AI Market by Technology (ML, NLP, Image Processing and Face Recognition), Vertical (Transportation, Healthcare, Government & Public Sector, Energy & Utilities, Agriculture, and Education & Training) and Region - Global Forecast to 2027
The global citizen services AI market size is projected to reach USD 41.0 billion by 2027, at a CAGR of 44.5% during the forecast period. Some of the major citizen services AI market vendors are IBM (US), ServiceNow (US), AWS (US), NVIDIA (US), Microsoft (US), Intel (US), Alfresco (US), Waymo (US), Voyager Labs (US), Accenture (Ireland), Alibaba (China), Tencent (China), Pegasystems (US), Baidu (China), Automation Anywhere (US), OpenText (Canada), H2O.AI (US), and ADDO (Singapore).
- Published: November 2022
- Price: $ 4950
- TOC Available:
-
Europe Artificial Intelligence (AI) in Healthcare Market by Offering (Integrated), Function (Diagnosis, Genomic, Precision Medicine, Radiation, Telehealth, RPM, Immunotherapy, Supply Chain), Application (Clinical), End User (Hospitals) - Forecast to 2030
The Europe Artificial Intelligence (AI) in Healthcare Market, valued at USD 4.20 billion in 2024, stood at USD 6.12 billion in 2025 and is projected to advance at a resilient CAGR of 39.0% from 2025 to 2030, culminating in a forecasted valuation of USD 31.72 billion by the end of the period. This growth is driven by strong regulatory support for digital transformation and the rising adoption of AI-enabled clinical workflows across European health systems.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
US Artificial Intelligence (AI) in Healthcare Market by Offering (Integrated), Function (Diagnosis, Genomic, Precision Medicine, Radiation, Telehealth, Immunotherapy, Pharmacy, Supply Chain), Application (Clinical), End User (Hospitals) - Forecast to 2030
The US artificial intelligence (AI) in healthcare market, valued at US$5.98 billion in 2024, stood at US$8.65 billion in 2025 and is projected to advance at a resilient CAGR of 38.0% from 2025 to 2030, culminating in a forecasted valuation of US$43.30 billion by the end of the period. Market growth is driven by rising demand from providers for automation, nationwide labor shortages, increasing clinical complexity, and strong investment in predictive analytics, imaging AI, and GenAI.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Artificial Intelligence (AI) Toolkit Market by Offering (Hardware, Software, Services), Technology (Natural Language Processing, Machine Learning), Vertical (BFSI, Retail & eCommerce, Healthcare & Life Sciences) and Region - Global Forecast to 2028
The AI Toolkit market is projected to reach USD 91.6 billion by 2028, at a Compound Annual Growth Rate (CAGR) of 36.2% during the forecast period. The major vendors covered in the AI Toolkit market include Microsoft (US), Google (US), IBM (US), Oracle (US), Thales Group (France), Salesforce (US), Intel (US), Adobe (US), Meta Platforms (US), AWS (US), NVIDIA Corporation (US), H2O.ai (US), Alteryx (US), Altair (US), KNIME (Switzerland), DataRobot (US), Jasper (US), Rasa (US), SuperAnnotate (US), OpenAI (US), Obviously AI (US), Fiddler AI (US), Determined AI (US), Snorkel AI (US), Levity AI (Germany), Union AI (US), Attri AI (US), Regie.ai (US). These players have adopted various growth strategies, such as partnerships, agreements and collaborations, new product launches, enhancements, and acquisitions to expand their footprint in the AI Toolkit market.
- Published: October 2023
- Price: $ 4950
- TOC Available:
-
Embedded AI Market by Offering (Hardware, Software, Services), Data Type (Numerical Data, Categorical Data, Image & Video Data), Vertical (Automotive, Manufacturing, Healthcare & Life Sciences, Telecom), and Region - Global Forecast to 2028
The embedded AI market is projected to reach USD 18.0 billion by 2028, at a CAGR of 14.0% during the forecast period. Some major players in the Embedded AI market include Google (US), IBM (US), Microsoft (US), AWS (US), NVIDIA (US), Intel (US), Qualcomm (US), Arm (UK), AMD (US), MediaTek (Taiwan), Oracle (US), Salesforce (US), NXP (The Netherlands), Lattice (US), Octonion (Switzerland), NeuroPace (US), Siemens (Germany), HPE (US), LUIS Technology (Germany), Code Time Technologies (Canada), HiSilicon (China), VectorBlox (Canada), AU-Zone Technologies (Canada), STMicroelectronics (Switzerland), SenseTime (Hong Kong), Edge Impulse (US), Perceive (US), Eta Compute (US), SensiML (US), Syntiant (US), Graphcore (UK), and SiMa.ai (US).
- Published: June 2023
- Price: $ 4950
- TOC Available:
-
Larvicides Market by Control Method (Biocontrol Agents, Chemical Agents, Insect Growth Regulators), Target (Mosquitoes, Flies), End-use Sector (Public Health, Agricultural, Commercial, Residential, Livestock), and Region - Global Forecast to 2023
The larvicides market is estimated at USD 751.6 Million in 2018, and is projected to reach USD 952.7 Million by 2023, at a CAGR of 4.86% during the forecast period. The market is primarily driven by factors such as vector-based epidemics or outbreaks, climatic changes, the rise in pest population, worldwide, and growth in awareness about IPM practices and environmental sustainability. This report includes a study of marketing and development strategies, along with the product portfolios of leading companies which includes Bayer (Germany), BASF (Germany), Gowan Company (US), Sumitomo Chemical (Japan), Nufarm (Australia), Certis (US), Summit Chemical (US), Syngenta (Switzerland), Adama (Israel), Eli Lily and Company (US), Russell IPM (UK), and Central Garden & Pet Co. (US).
- Published: May 2018
- Price: $ 4950
- TOC Available:
-
Embolotherapy Market by Product (Embolic Agents (Microspheres, Liquid Embolic Agents, Coil), Microcatheters), Indication (Oncology, Vascular, Aneurysm, Urology, Nephrology), Procedure (TACE, TARE), Enduser (Hospital, Clinics, ASC) - Global Forecast to 2026
The global embolotherapy market boasts a total value of $3.4 billion in 2021 and is projected to register a growth rate of 8.0% to reach a value of $5.0 billion by 2026. The major players in the market include Boston Medical Corporation (US), Terumo Medical Systems (Japan), Medtronic (US), Johnson & Johnson (US), and Stryker Corporation (US). Other key players in the embolization therapy market include Sirtex Medical Limited (US), Abbott Laboratories (US), Acandis GmbH (Germany), Balt (France), Cook Medical (US), Kaneka Corporation (Japan), Penumbra, Inc. (US), Merit Medical Systems (US), Meril Life Sciences Pvt. Ltd. (India), Cardiva (US), Shape Memory Medical Inc. (US), Artio Medical Inc. (US), Rapid Medical (US), Emboline, Inc. (US), and IMbiotechnologies Ltd. (Canada), among others.
- Published: May 2021
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
